在使用那他珠单抗、β-干扰素和醋酸格拉替雷进行疾病修正治疗期间的多发性硬化症相关疲劳。 - Suppr

Suppr

超能文献

Multiple sclerosis-associated fatigue during disease-modifying treatment with natalizumab, interferon-beta and glatiramer acetate.

作者信息

Yildiz Murat, Tettenborn Barbara, Putzki Norman

出版信息

Eur Neurol. 2011;65(4):231-2. doi: 10.1159/000324028. Epub 2011 Mar 31.

DOI:10.1159/000324028

PMID:21454981

Abstract

摘要

相似文献

Multiple sclerosis-associated fatigue during disease-modifying treatment with natalizumab, interferon-beta and glatiramer acetate.在使用那他珠单抗、β-干扰素和醋酸格拉替雷进行疾病修正治疗期间的多发性硬化症相关疲劳。

Eur Neurol. 2011;65(4):231-2. doi: 10.1159/000324028. Epub 2011 Mar 31.

[Glatiramer acetate in interferon beta non respondent relapsing-remitting multiple sclerosis].醋酸格拉替雷用于对β-干扰素无反应的复发缓解型多发性硬化症

Neurologia. 2009 Sep;24(7):435-8.

Current disease-modifying therapies in multiple sclerosis.目前用于治疗多发性硬化症的疾病修正疗法。

Semin Neurol. 2003 Jun;23(2):133-46. doi: 10.1055/s-2003-41138.

Treatment patterns in disease-modifying therapy for patients with multiple sclerosis in the United States.美国多发性硬化症患者在疾病修正治疗中的治疗模式。

Clin Ther. 2013 Oct;35(10):1501-12. doi: 10.1016/j.clinthera.2013.07.330.

[Immunomodulatory therapy in multiple sclerosis].[多发性硬化症的免疫调节治疗]

Ideggyogy Sz. 2004 Nov 20;57(11-12):401-16.

Glatiramer: new preparation. No place in multiple sclerosis.格拉替雷：新制剂。在多发性硬化症治疗中无立足之地。

Prescrire Int. 2004 Feb;13(69):10-2.

Effects of glatiramer acetate on spasticity in previously interferon-beta-treated and treatment-naive patients with relapsing-remitting multiple sclerosis: a prospective, nonrandomized, open-label, uncontrolled, observational pilot study.醋酸格拉替雷对既往接受干扰素-β治疗和初治的复发缓解型多发性硬化症患者痉挛的影响：一项前瞻性、非随机、开放标签、非对照、观察性研究。

Clin Ther. 2010 Jun;32(6):1061-6. doi: 10.1016/j.clinthera.2010.06.005.

Anti-depressant use in association with interferon and glatiramer acetate treatment in multiple sclerosis.在多发性硬化症中，抗抑郁药与干扰素和醋酸格拉替雷联合使用。

Mult Scler. 2008 Apr;14(3):406-11. doi: 10.1177/1352458507082942. Epub 2007 Nov 6.

[Update on current care guidelines: multiple sclerosis].[当前护理指南更新：多发性硬化症]

Duodecim. 2013;129(5):548-9.

Natalizumab plus interferon beta-1a for relapsing multiple sclerosis.那他珠单抗联合干扰素β-1a治疗复发型多发性硬化症。

N Engl J Med. 2006 Mar 2;354(9):911-23. doi: 10.1056/NEJMoa044396.

引用本文的文献

Impact of Disease Modifying Therapy on MS-Related Fatigue: A Narrative Review.疾病修饰疗法对多发性硬化症相关疲劳的影响：一项叙述性综述。

Brain Sci. 2023 Dec 20;14(1):4. doi: 10.3390/brainsci14010004.

Intravenous or subcutaneous natalizumab in patients with relapsing-remitting multiple sclerosis: investigation on efficiency and savings-the EASIER study.静脉内或皮下注射那他珠单抗治疗复发缓解型多发性硬化症患者：疗效和节省成本的调查——EASIER 研究。

J Neurol. 2024 Jan;271(1):340-354. doi: 10.1007/s00415-023-11955-0. Epub 2023 Sep 16.

Multiple sclerosis-related fatigue lacks a unified definition: A narrative review.多发性硬化症相关疲劳缺乏统一的定义：一项叙述性综述。

J Res Med Sci. 2022 Mar 17;27:24. doi: 10.4103/jrms.jrms_1401_20. eCollection 2022.

Is there a link between inflammation and fatigue in multiple sclerosis?多发性硬化症中炎症与疲劳之间存在联系吗？

J Inflamm Res. 2018 Jun 7;11:253-264. doi: 10.2147/JIR.S167199. eCollection 2018.

Fatigue as a symptom or comorbidity of neurological diseases.疲劳作为神经疾病的一种症状或合并症。

Nat Rev Neurol. 2017 Nov;13(11):662-675. doi: 10.1038/nrneurol.2017.117. Epub 2017 Oct 13.

Inflammation and the Silent Sequelae of Stroke.炎症与中风的隐匿后遗症

Neurotherapeutics. 2016 Oct;13(4):801-810. doi: 10.1007/s13311-016-0451-5.

The representation of inflammatory signals in the brain - a model for subjective fatigue in multiple sclerosis.大脑中炎症信号的表现——多发性硬化症主观疲劳的一种模型。

Front Neurol. 2014 Dec 11;5:264. doi: 10.3389/fneur.2014.00264. eCollection 2014.

Multiple sclerosis symptom recrudescence at the end of the natalizumab dosing cycle.那他珠单抗给药周期结束时多发性硬化症状复发。

Int J MS Care. 2014 Summer;16(2):92-8. doi: 10.7224/1537-2073.2013-017.

Changes in Fatigue and Cognition in Patients with Relapsing Forms of Multiple Sclerosis Treated with Natalizumab: The ENER-G Study.那他珠单抗治疗复发型多发性硬化症患者的疲劳和认知变化：ENER-G研究。

Int J MS Care. 2013 Fall;15(3):120-8. doi: 10.7224/1537-2073.2012-043.

Natalizumab treatment reduces fatigue in multiple sclerosis. Results from the TYNERGY trial; a study in the real life setting.那他珠单抗治疗可减轻多发性硬化症患者的疲劳。TYNERGY 试验的结果；真实环境下的一项研究。

PLoS One. 2013;8(3):e58643. doi: 10.1371/journal.pone.0058643. Epub 2013 Mar 21.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验